Nucs AI and AstraZeneca Collaborate on AI Response Prediction for Radioconjugate Research

May 29, 2026
Nucs AI has announced a collaboration with AstraZeneca to develop AI models that predict patient response to PSMA-targeted radioconjugate therapies for metastatic prostate cancer.

Nucs AI has announced a collaboration with AstraZeneca to develop AI models that predict patient response to PSMA targeted radioconjugate therapies for metastatic prostate cancer, according to a press release.

The project will focus on adapting and validating predictive imaging algorithms for radioconjugates used in metastatic castration resistant prostate cancer. The models will be tuned to the properties of emerging therapies, building on Nucs AI's existing work in Lutetium based therapy prediction.

The collaboration extends Nucs AI's platform, which includes SelectPSMA for outcome prediction, DeepPSMA for tumor burden quantification, and TrackPSMA for automated treatment response evaluation. These tools form part of the company's precision medicine engine designed to support the development and optimization of therapeutic radioconjugates.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Enterprise AI Brief, Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Enterprise AI Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Enterprise

05/29
Kao Data Names Spencer Lamb as Chief Executive Officer
05/29
Corner Names Michael Sonnenshein Partner and Group President
05/29
Zendure and Sunergy Partner to Advance Smart Home Energy Management in the Netherlands
05/29
Bitwise and HoneyHive Partner to Advance Enterprise AI Governance
05/29
Huawei Named Leader in Gartner Magic Quadrant for Enterprise LAN Infrastructure

More from: Life Sciences

05/29
Holmusk Expands NeuroBlu Dataset to 46 Million Patients with Neurology and Biomarker Data
05/29
SKIA HEAD AR Surgical Guidance System Gains FDA Clearance
05/29
Cognizant Opens TriZetto Unify Platform to AI Agents for Prior Authorization
05/29
World Health Expo Miami 2026 to Spotlight AI and Robotics in Healthcare
05/29
Causaly Introduces Scientific Workflows for Automated Life Sciences Research

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Market report

2025 Generative AI in Professional Services Report

Thomson Reuters

This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.

Read more

You May Also Like